Infliximab‐induced autoimmune hepatitis requiring liver transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Infliximab‐induced autoimmune hepatitis requiring liver transplantation

Published:2019-09-27 Issue:11 Volume:7 Page:2135-2139
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Wong Frederick¹^ORCID,Al Ibrahim Bashaar¹²,Walsh Joanna³,Qumosani Karim¹

Affiliation:

1. Division of Gastroenterology Department of Internal Medicine Western University London Ontario Canada

2. Department of Medicine King Faisal Special Hospital and Research Centre Riyadh Saudi Arabia

3. Department of Pathology and Laboratory Medicine Western University London Ontario Canada

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.2456

Reference32 articles.

1. Autoimmune Diseases Induced by TNF-Targeted Therapies

2. Concomitant Vitiligo and Psoriasis in a Patient Treated with Interferon Alfa-2a for Chronic Hepatitis B Infection

3. Autoimmune Hepatitis Induced by Infliximab in a Patient with Crohnʼs Disease with no Relapse After Switching to Adalimumab

4. Infliximab-Induced Autoimmune Hepatitis with Successful Switch to Adalimumab in a Patient with Crohn’s disease: The Index Case

5. Autoimmune hepatitis during infliximab therapy for Crohn's disease: A case report

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-Induced Liver Injury due to Biologics and Immune Check Point Inhibitors;Medical Clinics of North America;2023-05

2. Ustekinumab-induced autoimmune hepatitis: about a case report;Pan African Medical Journal;2023

3. Advancing Biologic Therapy for Refractory Autoimmune Hepatitis;Digestive Diseases and Sciences;2022-02-11

4. Psoriasis comorbidities and clinical implications when using biologics;Dermatological Reviews;2021-09-02

5. Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes;Cancers;2021-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3